PE anti-human CD73 Ecto-5-nucleotidase Antibody anti-CD73 - AD2,BioLegend,344003

Additional reported applications (for the relevant formats) include:immunofluorescence3.Clone AD2 has been noted to induce clustering and internalization of CD73in vivoand inhibit metastasis in a murine breast cancer xenograft model4.

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB953889024

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePE anti-human CD73 Ecto-5-nucleotidase Antibody anti-CD73 - AD2
Cat. No.344003
HostMouse
RRIDAB_1877224 (BioLegend Cat. No. 344003)AB_2298698 (BioLegend Cat. No. 344004)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone NumberAD2
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetCD73
PurityThe antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD73 is a 70 kD glycophosphatidylinositol (GPI)-linked 5'-nucleotidase, which is also known as ecto-5'-nucleotidase. It converts adenosine monophosphate (AMP) to adenosine. CD73 is expressed on subsets of T and B cells, mesenchymal stem cells, follicular dendritic cells, endothelial cells, and epithelial cells. It has been reported that CD73 costimulates T cell activation, and mediates adhesion of lymphocytes to follicular dendritic cells and endothelial cells.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.